Results for tag: "Antifibrinolytic"

Antifibrinolytic drugs are a class of hematological drugs used to reduce the breakdown of blood clots. They are used to treat and prevent excessive bleeding in a variety of conditions, including hemophilia, trauma, surgery, and childbirth. Antifibrinolytics work by inhibiting the activity of plasmin, an enzyme that breaks down fibrin, the main component of blood clots. This helps to stabilize the clot and reduce bleeding. Common antifibrinolytic drugs include tranexamic acid, aminocaproic acid, and epsilon aminocaproic acid. The antifibrinolytic market is a growing segment of the hematological drugs market. It is driven by the increasing prevalence of bleeding disorders, the growing demand for minimally invasive surgeries, and the increasing use of antifibrinolytics in obstetrics and gynecology. Some companies in the antifibrinolytic market include Pfizer, Novartis, Bayer, Sanofi, and Merck. Show Less Read more